SCHEMBL5799

SCHEMBL5799

O=[N+]([O-])c1ccc(OC(F)C(F)F)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPB1 P04792 2/20 0.54
MAPT P10636 6/20 0.49
NPSR1 Q6W5P4 2/20 0.49
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
PABPC1 P11940 2/20 0.45
GAA P10253 3/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ALOX12 P18054 2/20 0.40
CYP2C19 P33261 1/20 0.40
ADRA2A P08913 2/20 0.40
ADRA2B P18089 2/20 0.40
ADRA2C P18825 2/20 0.40
SLC2A1 P11166 1/20 0.40
RAB9A P51151 1/20 0.39
LMNA P02545 3/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
POLB P06746 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29974305 0.87 HSPB1 (0.56) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL558792 0.87 HSPB1 (0.56) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL11618 0.82 MAPT (0.44) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL306639 0.80 HSPB1 (0.53) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL1360440 0.79 MAPT (0.58) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL29199065 0.77 HSPB1 (0.50) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL11590 0.77 MAPT (0.52) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL745282 0.77 MAPT (0.52) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL27449389 0.77 HSPB1 (0.70) HSPB1MAPTNPSR1MEN1KMT2A
SCHEMBL1851173 0.74 KMT2A (0.70) HSPB1MAPTNPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed